Pfizer Inc
NYSE:PFE

Watchlist Manager
Pfizer Inc Logo
Pfizer Inc
NYSE:PFE
Watchlist
Price: 26.19 USD -0.08% Market Closed
Market Cap: 148.4B USD
Have any thoughts about
Pfizer Inc?
Write Note

Intrinsic Value

The intrinsic value of one PFE stock under the Base Case scenario is 24.53 USD. Compared to the current market price of 26.19 USD, Pfizer Inc is Overvalued by 6%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

PFE Intrinsic Value
24.53 USD
Overvaluation 6%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Pfizer Inc

Intrinsic Value History
Dive into the past to invest in the future

Uncover deeper insights with the Valuation History. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start now and learn if your stock is truly undervalued or overvalued!

Start Valuation
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
PFE
Valuation History
HIDDEN
Show
Valuation History Unavailable

Historical valuation for PFE cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...

Fundamental Analysis

Company Overview
Loading...
Business Segments
Loading...
Economic Moat
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
Bear Theses

Pfizer’s revenue from its COVID-19 vaccine may sharply fall as the pandemic fades, creating reliance on a still-emerging pipeline that may struggle to offset the loss of high-margin vaccine income.

Patent expirations on blockbuster drugs like Ibrance and Xeljanz pose a significant threat to long-term sales growth, as cheaper generics or biosimilars could rapidly erode market share.

Amid rising scrutiny over drug pricing and intensifying regulatory efforts in major markets, Pfizer's historically premium-priced portfolio may face margin pressure and unpredictable pricing environments.

Bull Theses

A robust late-stage pipeline in immunology, oncology, and vaccine segments could yield multiple blockbuster approvals, helping Pfizer not only offset patent-cliff losses but also drive new revenue growth.

The company’s healthy balance sheet and solid cash flows enable strategic acquisitions of smaller biotech innovators, bolstering Pfizer’s R&D capabilities and strengthening its future product portfolio.

Pfizer’s successful collaboration with BioNTech on the COVID-19 vaccine highlights growing expertise in mRNA technology, positioning the firm to capitalize on novel treatments and next-generation vaccines beyond the pandemic.

Show More Less
How do you feel about PFE?
Bearish
Neutral
Bullish
AI Assistant
AI Assistant
Ask me anything about Pfizer Inc

Provide an overview of the primary business activities
of Pfizer Inc.

What unique competitive advantages
does Pfizer Inc hold over its rivals?

What risks and challenges
does Pfizer Inc face in the near future?

Has there been any significant insider trading activity
in Pfizer Inc recently?

Summarize the latest earnings call
of Pfizer Inc.

What significant events have occurred
in Pfizer Inc over the past months?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Pfizer Inc.

Provide P/S
for Pfizer Inc.

Provide P/E
for Pfizer Inc.

Provide P/OCF
for Pfizer Inc.

Provide P/FCFE
for Pfizer Inc.

Provide P/B
for Pfizer Inc.

Provide EV/S
for Pfizer Inc.

Provide EV/GP
for Pfizer Inc.

Provide EV/EBITDA
for Pfizer Inc.

Provide EV/EBIT
for Pfizer Inc.

Provide EV/OCF
for Pfizer Inc.

Provide EV/FCFF
for Pfizer Inc.

Provide EV/IC
for Pfizer Inc.

Show me price targets
for Pfizer Inc made by professional analysts.

What are the Revenue projections
for Pfizer Inc?

How accurate were the past Revenue estimates
for Pfizer Inc?

What are the Net Income projections
for Pfizer Inc?

How accurate were the past Net Income estimates
for Pfizer Inc?

What are the EPS projections
for Pfizer Inc?

How accurate were the past EPS estimates
for Pfizer Inc?

What are the EBIT projections
for Pfizer Inc?

How accurate were the past EBIT estimates
for Pfizer Inc?

Compare the revenue forecasts
for Pfizer Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Pfizer Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Pfizer Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of Pfizer Inc compared to its peers.

Compare the P/E ratios
of Pfizer Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing Pfizer Inc with its peers.

Analyze the financial leverage
of Pfizer Inc compared to its main competitors.

Show all profitability ratios
for Pfizer Inc.

Provide ROE
for Pfizer Inc.

Provide ROA
for Pfizer Inc.

Provide ROIC
for Pfizer Inc.

Provide ROCE
for Pfizer Inc.

Provide Gross Margin
for Pfizer Inc.

Provide Operating Margin
for Pfizer Inc.

Provide Net Margin
for Pfizer Inc.

Provide FCF Margin
for Pfizer Inc.

Show all solvency ratios
for Pfizer Inc.

Provide D/E Ratio
for Pfizer Inc.

Provide D/A Ratio
for Pfizer Inc.

Provide Interest Coverage Ratio
for Pfizer Inc.

Provide Altman Z-Score Ratio
for Pfizer Inc.

Provide Quick Ratio
for Pfizer Inc.

Provide Current Ratio
for Pfizer Inc.

Provide Cash Ratio
for Pfizer Inc.

What is the historical Revenue growth
over the last 5 years for Pfizer Inc?

What is the historical Net Income growth
over the last 5 years for Pfizer Inc?

What is the current Free Cash Flow
of Pfizer Inc?

Discuss the annual earnings per share (EPS)
trend over the past five years for Pfizer Inc.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Pfizer Inc

Current Assets 43.2B
Cash & Short-Term Investments 10B
Receivables 17.7B
Other Current Assets 15.6B
Non-Current Assets 176.3B
Long-Term Investments 10.8B
PP&E 18.5B
Intangibles 128.6B
Other Non-Current Assets 18.4B
Current Liabilities 43.2B
Accounts Payable 5.3B
Accrued Liabilities 3.4B
Short-Term Debt 6B
Other Current Liabilities 28.6B
Non-Current Liabilities 84B
Long-Term Debt 58B
Other Non-Current Liabilities 26B
Efficiency

Free Cash Flow Analysis
Pfizer Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Pfizer Inc

Revenue
63.6B USD
Cost of Revenue
-16.4B USD
Gross Profit
47.2B USD
Operating Expenses
-31B USD
Operating Income
16.2B USD
Other Expenses
-8.2B USD
Net Income
8B USD
Fundamental Scores

PFE Profitability Score
Profitability Due Diligence

Pfizer Inc's profitability score is 58/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive Free Cash Flow
Positive Operating Income
Positive 3-Year Average ROE
58/100
Profitability
Score

Pfizer Inc's profitability score is 58/100. The higher the profitability score, the more profitable the company is.

PFE Solvency Score
Solvency Due Diligence

Pfizer Inc's solvency score is 41/100. The higher the solvency score, the more solvent the company is.

Low D/E
Long-Term Solvency
Short-Term Solvency
Average Altman Z-Score
41/100
Solvency
Score

Pfizer Inc's solvency score is 41/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

PFE Price Targets Summary
Pfizer Inc

Wall Street analysts forecast PFE stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for PFE is 31.48 USD with a low forecast of 25.25 USD and a high forecast of 43.5 USD.

Lowest
Price Target
25.25 USD
4% Downside
Average
Price Target
31.48 USD
20% Upside
Highest
Price Target
43.5 USD
66% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for PFE is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

PFE Insider Trading
Buy and sell transactions by insiders

PFE News

Other Videos
What is the Intrinsic Value of one PFE stock?

The intrinsic value of one PFE stock under the Base Case scenario is 24.53 USD.

Is PFE stock undervalued or overvalued?

Compared to the current market price of 26.19 USD, Pfizer Inc is Overvalued by 6%.

Back to Top